Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration
- 13 August 2003
- journal article
- review article
- Published by Wiley in Journal of Neurochemistry
- Vol. 86 (6) , 1313-1327
- https://doi.org/10.1046/j.1471-4159.2003.01948.x
Abstract
Proteomics involves the identification of unknown proteins following their separation, often using two-dimensional electrophoresis, digestion of particular proteins of interest by trypsin, determination of the molecular weight of the resulting peptides, and database searching to make the identification of the proteins. Application of proteomics to Alzheimer's disease (AD), the major dementing disorder of the elderly, has just begun. Differences in protein expression and post-translational modification (mostly oxidative modification) of proteins from AD brain and peripheral tissue, as well as in brain from rodent models of AD, have yielded insights into potential molecular mechanisms of neurodegeneration in this dementing disorder. This review surveys the proteomics studies relevant to AD, from which new understandings of the pathology, biochemistry, and physiology of AD are beginning to emerge.Keywords
This publication has 82 references indexed in Scilit:
- Identification of oxidized plasma proteins in Alzheimer's diseaseBiochemical and Biophysical Research Communications, 2002
- Decreased brain levels of 2′,3′-cyclic nucleotide-3′-phosphodiesterase in Down syndrome and Alzheimer’s diseaseNeurobiology of Aging, 2001
- Brain t-complex polypeptide 1 (TCP-1) related to its natural substrate β1 tubulin is decreased in Alzheimer's diseaseLife Sciences, 2001
- Identification of the apolipoprotein E4 isoform in cerebrospinal fluid with preparative two-dimensional electrophoresis and matrix assisted laser desorption/ionization-time of flight-mass spectrometryElectrophoresis, 2001
- The reduction of NADH: Ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's diseaseLife Sciences, 2001
- Alteration of Caspases and Apoptosis-Related Proteins in Brains of Patients with Alzheimer's DiseaseBiochemical and Biophysical Research Communications, 2001
- Deranged Expression of Molecular Chaperones in Brains of Patients with Alzheimer's DiseaseBiochemical and Biophysical Research Communications, 2001
- Differential effects of apolipoprotein E isoforms on phosphorylation at specific sites on tau by glycogen synthase kinase‐3β identified by nano‐electrospray mass spectrometryFEBS Letters, 2000
- Analysis of blood plasma proteins in patients with Alzheimer's disease by two-dimensional electrophoresis, sequence homology and immunodetectionElectrophoresis, 2000
- Proteome analysis of mouse brain: Two-dimensional electrophoresis profiles of tissue proteins during the course of agingElectrophoresis, 2000